GREENLIGHT CAPITAL INC 13D and 13G filings for NeuBase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:32 pm Purchase | 2021-12-31 | 13G | NeuBase Therapeutics, Inc. NBSE | GREENLIGHT CAPITAL INC | 136,351 8.300% | 35,000 (+34.53%) | Filing |
| 2021-02-16 3:40 pm Purchase | 2021-02-16 | 13G | NeuBase Therapeutics, Inc. NBSE | GREENLIGHT CAPITAL INC | 101,351 8.700% | 24,428 (+31.76%) | Filing |